Leadership Team

Kola Otitoju

Chief Business & Strategy Officer

Kola Otitoju is Chief Business & Strategy Officer, having joined 908 Devices in April 2026, and brings more than 25 years of executive leadership in strategy, business development and P&L management across the medical technology, life sciences, and industrials sectors. Previously, Kola served as Senior Vice President of Strategy & Business Development at Repligen Corporation, where he led the company’s global corporate strategy and executed more than 15 M&A transactions and strategic partnerships over six years. While at Repligen, he also led the global operations of the company’s Bioprocessing Analytics Division, including commercial and service, marketing, new product development and manufacturing.

Prior to Repligen, Kola held senior strategy and business development roles at Candela Medical, Baxter International, and GE Healthcare. Earlier in his career he spent eight years in investment banking at Credit Suisse and Bank of America Securities. He also held engineering and operations positions at Lutron Electronics. Kola received a bachelor’s degree in information systems from Imperial College, London, a master’s degree in electrical engineering from Cornell University and an MBA from Harvard Business School.